Cargando…

Critical evaluation of asthma biomarkers in clinical practice

The advent of personalized medicine has revolutionized the whole approach to the management of asthma, representing the essential basis for future developments. The cornerstones of personalized medicine are the highest precision in diagnosis, individualized prediction of disease evolution, and patie...

Descripción completa

Detalles Bibliográficos
Autores principales:	Guida, Giuseppe, Bagnasco, Diego, Carriero, Vitina, Bertolini, Francesca, Ricciardolo, Fabio Luigi Massimo, Nicola, Stefania, Brussino, Luisa, Nappi, Emanuele, Paoletti, Giovanni, Canonica, Giorgio Walter, Heffler, Enrico
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9588982/ https://www.ncbi.nlm.nih.gov/pubmed/36300189 http://dx.doi.org/10.3389/fmed.2022.969243

Ejemplares similares

The Role of Dupilumab in Severe Asthma
por: Ricciardolo, Fabio Luigi Massimo, et al.
Publicado: (2021)

Which Therapy for Non-Type(T)2/T2-Low Asthma
por: Ricciardolo, Fabio L. M., et al.
Publicado: (2021)

Phenotype overlap in the natural history of asthma
por: Ricciardolo, Fabio L.M., et al.
Publicado: (2023)

Characterization of T2-Low and T2-High Asthma Phenotypes in Real-Life
por: Ricciardolo, Fabio Luigi Massimo, et al.
Publicado: (2021)

Clinical Characterization of the Frequent Exacerbator Phenotype in Asthma
por: Sprio, Andrea Elio, et al.
Publicado: (2020)

Reliability of Total Serum IgE Levels to Define Type 2 High and Low Asthma Phenotypes
por: Guida, Giuseppe, et al.
Publicado: (2023)

Biologics in Severe Eosinophilic Asthma: Three-Year Follow-Up in a SANI Single Center
por: Solidoro, Paolo, et al.
Publicado: (2022)

MicroRNAs as Biomarkers in Corticosteroid-Resistant/Neutrophilic Asthma: Still a Long Way to Go!
por: Ricciardolo, Fabio L. M., et al.
Publicado: (2020)

Economic impact of a more extensive use of FENO testing on the Italian population with asthma
por: Rognoni, Carla, et al.
Publicado: (2023)

Frequency of Tiotropium Bromide Use and Clinical Features of Patients with Severe Asthma in a Real-Life Setting: Data from the Severe Asthma Network in Italy (SANI) Registry
por: Puggioni, Francesca, et al.
Publicado: (2020)

Long-Term Safety of Antifibrotic Drugs in IPF: A Real-World Experience
por: Levra, Stefano, et al.
Publicado: (2022)

Biologics and airway remodeling in severe asthma
por: Varricchi, Gilda, et al.
Publicado: (2022)

Economic impact of mepolizumab in uncontrolled severe eosinophilic asthma, in real life()
por: Bagnasco, Diego, et al.
Publicado: (2021)

Interleukin-5 in the Pathophysiology of Severe Asthma
por: Pelaia, Corrado, et al.
Publicado: (2019)

Predictors of reversible airway obstruction with omalizumab in severe asthma: a real-life study
por: Solidoro, Paolo, et al.
Publicado: (2019)

Personalized Approach to Severe Asthma
por: Heffler, Enrico, et al.
Publicado: (2018)

Eosinophils Target Therapy for Severe Asthma: Critical Points
por: Brussino, L., et al.
Publicado: (2018)

Specific Therapy for T2 Asthma
por: Bagnasco, Diego, et al.
Publicado: (2022)

Long-Term Efficacy of Mepolizumab at 3 Years in Patients with Severe Asthma: Comparison with Clinical Trials and Super Responders
por: Bagnasco, Diego, et al.
Publicado: (2023)

Interleukin-5 pathway inhibition in the treatment of eosinophilic respiratory disorders: evidence and unmet needs
por: Varricchi, Gilda, et al.
Publicado: (2016)

Sex Differences in Severe Asthma: Results From Severe Asthma Network in Italy-SANI
por: Senna, Gianenrico, et al.
Publicado: (2020)

Type 2 immunity in asthma
por: Caminati, Marco, et al.
Publicado: (2018)

Effectiveness of omalizumab in patients with severe allergic asthma with and without chronic rhinosinusitis with nasal polyps: a PROXIMA study post hoc analysis
por: Heffler, Enrico, et al.
Publicado: (2020)

A critical appraisal on AIT in childhood asthma
por: Ferrando, Matteo, et al.
Publicado: (2018)

Reslizumab and Eosinophilic Asthma: One Step Closer to Precision Medicine?
por: Varricchi, Gilda, et al.
Publicado: (2017)

Patient and physician perspectives on biological treatment in severe asthma: a Severe Asthma Network Italy survey
por: Crimi, Claudia, et al.
Publicado: (2023)

Biologics in severe asthma: the role of real-world evidence from registries
por: Paoletti, Giovanni, et al.
Publicado: (2022)

The North-Western Italian experience with anti IL-5 therapy amd comparison with regulatory trials
por: Bagnasco, Diego, et al.
Publicado: (2018)

“Characteristics of patients admitted to emergency department for asthma attack: a real-LIFE study”
por: Losappio, Laura, et al.
Publicado: (2019)

Interleukins 4 and 13 in Asthma: Key Pathophysiologic Cytokines and Druggable Molecular Targets
por: Pelaia, Corrado, et al.
Publicado: (2022)

Mast Cells in Upper and Lower Airway Diseases: Sentinels in the Front Line
por: Costanzo, Giovanni, et al.
Publicado: (2023)

Severe asthma: One disease and multiple definitions
por: Bagnasco, Diego, et al.
Publicado: (2021)

Pragmatic Markers in the Management of Asthma: A Real-World-Based Approach
por: Ciprandi, Giorgio, et al.
Publicado: (2020)

Evolution in Endoscopic Sinus Surgery: The Adjuvant Role of Reboot Surgery in Patients with Uncontrolled Nasal Symptoms of Eosinophilic Granulomatosis with Polyangiitis
por: Pirola, Francesca, et al.
Publicado: (2023)

The Present and Future of Allergen Immunotherapy in Personalized Medicine
por: Ridolo, Erminia, et al.
Publicado: (2022)

Bone Morphogenic Proteins and Their Antagonists in the Lower Airways of Stable COPD Patients
por: Di Stefano, Antonino, et al.
Publicado: (2023)

Allergen immunotherapy for respiratory allergy: Quality appraisal of observational comparative effectiveness studies using the REal Life Evidence AssessmeNt Tool. An EAACI methodology committee analysis
por: Di Bona, Danilo, et al.
Publicado: (2021)

Choosing wisely in Allergology: a Slow Medicine approach to the discipline promoted by the Italian Society of Allergy, Asthma and Clinical Immunology (SIAAIC)
por: Heffler, Enrico, et al.
Publicado: (2015)

New Onset of Eosinophilic Granulomatosis with Polyangiitis Following mRNA-Based COVID-19 Vaccine
por: Nappi, Emanuele, et al.
Publicado: (2022)

Prospective Italian real‐world study of mepolizumab in severe eosinophilic asthma validates retrospective outcome reports
por: Pini, Laura, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_q5v15rpvhatgu6pus7kqs8al72